Drug Chatter -- Tracking biopharma stock chatter

Profile for Esperion Therapeutics, Inc. (ESPR)

« Back to company index

ESPR Chatter Timeline

Stock Ticker for ESPR

Most Active Tweeters for ESPR

UserTweets
@Lucy3370 6
@AmericanBanking 5
@AniuStudent 5
@skaushi 4
@iamdimitre 4

Recent Tweets for ESPR

stockelite @stockelite
$ESPR Esperion Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) https://t.co/Zksvew55PD
May 25th 2018, 5:05pm
GNWLive @GNWLive
Esperion Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) $ESPR https://t.co/aRKxzY54Ok
May 25th 2018, 4:05pm
StockTexts @StockTexts
$ESPR Esperion Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) Nasdaq:ESPR https://t.co/FwTquV4DpE
May 25th 2018, 4:05pm
InsiderAlertsIA @InsiderAlertsIA
$ESPR: New Insider Filing on Director NICOLE VITULLO: https://t.co/YiQF3y2SgZ
May 25th 2018, 4:05pm
darrenzh @darrenzh
RT @gcbioinv: $ESPR Chardan bull/bear case "Our statistical analyses suggest the imbalance of deaths across phase II/III trials may not be…
May 25th 2018, 3:05pm
BigChodu @BigChodu
@gcbioinv Haha... Chardan knows $espr the best. ? 2015 when retail was chasing $espr, they pretty much killed the stock. ????
May 25th 2018, 10:05am
gcbioinv @gcbioinv
$ESPR Chardan bull/bear case "Our statistical analyses suggest the imbalance of deaths across phase II/III trials m… https://t.co/V3IBTFKYIr
May 25th 2018, 9:05am
WeekHerald @WeekHerald
Insider Buying: Esperion Therapeutics Inc $ESPR Major Shareholder Purchases $5,214,300.00 in Stock https://t.co/DJybLu0OUd
May 25th 2018, 6:05am
dailypoliticaln @dailypoliticaln
Esperion Therapeutics Inc $ESPR Major Shareholder Purchases $2,112,000.00 in Stock https://t.co/sUcNJJ64DH
May 25th 2018, 4:05am
TickerReport @TickerReport
Esperion Therapeutics Inc $ESPR Major Shareholder Purchases $2,112,000.00 in Stock https://t.co/BxcWr1yqM7
May 25th 2018, 4:05am
TranscriptDaily @TranscriptDaily
Insider Buying: Esperion Therapeutics Inc $ESPR Major Shareholder Purchases $5,214,300.00 in Stock https://t.co/RfuE8Rniww
May 25th 2018, 4:05am
ledgerzette @ledgerzette
-$1.76 Earnings Per Share Expected for Esperion Therapeutics Inc $ESPR This Quarter https://t.co/ihk0ZSJvLs
May 24th 2018, 8:05pm
GummieDropout @GummieDropout
RT @zbiotech: $ESPR no deaths in either group 24wk LDL reductions: 26% vs 2% (tx/control) 12wk LDL reductions: 23% vs 1%
May 24th 2018, 3:05pm
ChartMill @ChartMill
$ESPR has a bad technical rating, but it does show a decent setup pattern. https://t.co/vQkx8zKyJI https://t.co/2BxbBouRdg
May 24th 2018, 8:05am
dispatchtribune @dispatchtribune
Target N. V. Biotech Buys 50,000 Shares of Esperion Therapeutics Inc $ESPR Stock https://t.co/0ZFl5Ryiwi
May 24th 2018, 5:05am
WatchlistN @WatchlistN
Esperion Therapeutics $ESPR Shares Down 10.1% https://t.co/C5cqsRhZXF
May 24th 2018, 12:05am
TickerReport @TickerReport
Esperion Therapeutics $ESPR Trading Down 10.1% https://t.co/IalmNVycxs
May 24th 2018, 12:05am
ledgerzette @ledgerzette
Esperion Therapeutics $ESPR Shares Down 10.1% https://t.co/2SfoKMG8f8
May 24th 2018, 12:05am
CI4CC @CI4CC
RT @Sports_bios: $MDGL NASH 36 wk liver biops and $ESPR P3 are two remaining data events on my watch list for the month.. then #ASCO18 com…
May 23rd 2018, 10:05pm
investpro2000 @investpro2000
RT @Lin_ling_88: $ESPR’s Top Holder Buys $5.2 Million More in Stock https://t.co/FFPDJdDZZL
May 23rd 2018, 10:05pm
investpro2000 @investpro2000
RT @JohnCendpts: Answer is no; shares down 3% -- $ESPR New PhIII gives Esperion’s CEO a chance to push back against a legion of critics — b…
May 23rd 2018, 10:05pm
iamdimitre @iamdimitre
What were the SAEs in trial? Report patients with increased liver enzyme ratio, but what were absolute levels of liver enzymes? $ESPR
May 23rd 2018, 8:05pm
TheBiotechBeat @TheBiotechBeat
RT @gcbioinv: $ESPR 0.5% fatality in drug arm vs 0.2% PBO
May 23rd 2018, 8:05pm
TheBiotechBeat @TheBiotechBeat
RT @ByJonGardner: I don't think this latest $ESPR data changes much. It seems like this population is prime for a PCSK9, especially if you…
May 23rd 2018, 8:05pm
Flight_Refunds @Flight_Refunds
RT @JosephRamelli: Another big imbalance in SAE in $ESPR trial. Almost double the SAEs in BA vs. placebo. Again ESPR says they are not drug…
May 23rd 2018, 6:05pm
BioPharmaDive @BioPharmaDive
Esperion plans to submit an NDA for the bempedoic acid monotherapy and combo therapy no later than Q1 2019 https://t.co/c8lyM5edFw $ESPR
May 23rd 2018, 5:05pm
AniuStudent @AniuStudent
@datamonitor_JA U can wait w/ bated breath 4the combo results but as JMP said 2day $ESPR results show BA’s safe, ef… https://t.co/h6xK7CUvIa
May 23rd 2018, 4:05pm
skathire @skathire
RT @datamonitor_JA: $ESPR P3 trial in statin intolerant patients, again we see a troublesome difference in the rate of SAEs, will need furt…
May 23rd 2018, 4:05pm
ainsley_ris @ainsley_ris
RT @theflynews: JMP Securities says Esperion Study 3 results look "solid" and safety data "clean": https://t.co/NDaPhPuhVi $ESPR
May 23rd 2018, 4:05pm
DJ_Jeff_Polar1 @DJ_Jeff_Polar1
RT @ARTRADING125: shout out to the indicators that don't work, bought the $ESPR bounce 36.1 back to 38! https://t.co/lUyj5IUrNq
May 23rd 2018, 3:05pm
ARTRADING125 @ARTRADING125
shout out to the indicators that don't work, bought the $ESPR bounce 36.1 back to 38! https://t.co/lUyj5IUrNq
May 23rd 2018, 3:05pm
theflynews @theflynews
JMP Securities says Esperion Study 3 results look "solid" and safety data "clean": https://t.co/NDaPhPuhVi $ESPR
May 23rd 2018, 3:05pm
wulamkam @wulamkam
$espr break down target may be a gap fill $25 or lower https://t.co/9T42XBOEUL
May 23rd 2018, 2:05pm
wulamkam @wulamkam
$espr looks like bear flag break down confirmed and waiting for the 50 200 DMA bearish cross https://t.co/r1tkn44Uxl
May 23rd 2018, 2:05pm
Lin_ling_88 @Lin_ling_88
$ESPR’s Top Holder Buys $5.2 Million More in Stock https://t.co/FFPDJdDZZL
May 23rd 2018, 1:05pm
portefeuillefun @portefeuillefun
RT @BioPharmaDive: $ESPR talks cholesterol drug pricing after third positive study https://t.co/c8lyM5edFw
May 23rd 2018, 1:05pm
BioPharmaDive @BioPharmaDive
$ESPR talks cholesterol drug pricing after third positive study https://t.co/c8lyM5edFw
May 23rd 2018, 12:05pm
Sanctuary_Bio @Sanctuary_Bio
$ESPR given the criticisms of biotwitter before the market even opened, the sell-the-news reaction should not be a… https://t.co/qGr2Hi8aFb
May 23rd 2018, 12:05pm
thakinish @thakinish
Wow $ESPR holy sell the news
May 23rd 2018, 12:05pm
haodongvli @haodongvli
$ESPR similar to $CARA, it will have a strategic partnership soon! Squeeze soon!
May 23rd 2018, 12:05pm
JohnCendpts @JohnCendpts
Answer is no; shares down 3% -- $ESPR New PhIII gives Esperion’s CEO a chance to push back against a legion of crit… https://t.co/obxWfkJQVQ
May 23rd 2018, 11:05am
JorelLaraKalel @JorelLaraKalel
Esperion Therapeutics Shares Briefly Halted on Late-Stage Cholesterol Trial $ESPR https://t.co/RBb2qswaLz
May 23rd 2018, 11:05am
Nonfiction8879 @Nonfiction8879
$ESPR green red green red green red green red green red green red green red .. investors know exactly what to think about the data ?
May 23rd 2018, 10:05am
Datamonitor_HC @Datamonitor_HC
RT @datamonitor_JA: $ESPR is attempting to calm fears by displaying aggregate safety data I find this misleading as many of the P2 trials…
May 23rd 2018, 10:05am
Briefingcom @Briefingcom
$ESPR: Esperion Therapeutics announces 'positive' top-line results from the third of five pivotal Phase 3 studies... https://t.co/gNJN1zL7A0
May 23rd 2018, 10:05am
ApexOneTrading @ApexOneTrading
$ESPR nothing like a squeeze in the morning
May 23rd 2018, 9:05am
AniuStudent @AniuStudent
Like it or not, compared to other approved statins, $ESPR already has enough solid safe&effective P3 data to be ent… https://t.co/ooDpcKUfh9
May 23rd 2018, 9:05am
redacre @redacre
$ESPR long CC and long Q&A session -> lots of interest in this drug - & analysts trying to parse each tidbit.
May 23rd 2018, 9:05am
whotrades @whotrades
Esperion Announces Third Pivotal Phase 3 Study of Bempedoic Acid Meets Primary Endpoint $ESPR… https://t.co/SgQUvpZlkK
May 23rd 2018, 9:05am
RolfeNeelsen @RolfeNeelsen
RT @Sports_bios: $ESPR guess people will ask about the dropout rate in treated grp - at 18%
May 23rd 2018, 9:05am

Contact © thinkBiotech LLC 2004 - 2018. All rights reserved.